IL6 and rheumatoid arthritis: A study revealed that IL-6 has the potential to facilitate the interaction between recombinant cathepsin B (CTSB) and NLRP3 via the CTSB/ATP pathway, thereby initiating the activation of the inflammasome and subsequently inducing RA.